Friday, 19 April 2024
Apellis Pharmaceuticals Inc.
NASDAQ : APLS
56.94 14 Oct 22 00:00 | Change: 1.78 | Open: 59.31 | High: 59.90 | Ask: 0.00 | Volume: 874,700 |
Change(%): 3.03 | Prev: 58.72 | Low: 56.15 | Bid: 0.00 | Avg vol: 0 |
04:22 | 18/3/18
Frisco Fastball
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) has 0.00% since March 18, 2017 and is . It has underperformed by 16.70% the S&P500.
more»
03:37 | 18/3/18
The Lincolnian Online
Apellis Pharmaceuticals logo Shares of Apellis Pharmaceuticals Inc (NASDAQ:APLS) have earned a consensus broker rating score of 1.00 (Strong Buy) from the four brokers that cover the stock, Zacks Investment Research reports.
more»
00:36 | 18/3/18
The Ledger Gazette
News coverage about Apellis Pharmaceuticals (NASDAQ:APLS) has trended somewhat positive this week, according to Accern. Accern scores the sentiment of media coverage by monitoring more than 20 million blog and news sources in real-time.
more»
03:44 | 17/3/18
Stocks Gallery
In recent trading day Celldex Therapeutics, Inc. (CLDX) stock showed the move of -2.35% with the closing price of $2.49.
more»
09:15 | 16/3/18
Frisco Fastball
Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases.
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |